JP2013544510A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544510A5
JP2013544510A5 JP2013535585A JP2013535585A JP2013544510A5 JP 2013544510 A5 JP2013544510 A5 JP 2013544510A5 JP 2013535585 A JP2013535585 A JP 2013535585A JP 2013535585 A JP2013535585 A JP 2013535585A JP 2013544510 A5 JP2013544510 A5 JP 2013544510A5
Authority
JP
Japan
Prior art keywords
sequence
rna
nucleotides
length
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013535585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013544510A (ja
Filing date
Publication date
Priority claimed from PCT/IL2010/000895 external-priority patent/WO2012056441A1/en
Application filed filed Critical
Publication of JP2013544510A publication Critical patent/JP2013544510A/ja
Publication of JP2013544510A5 publication Critical patent/JP2013544510A5/ja
Pending legal-status Critical Current

Links

JP2013535585A 2010-10-28 2011-10-27 細胞において外来性rnaを特異的に切断するための組成物および方法 Pending JP2013544510A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ILPCT/IL2010/000895 2010-10-28
PCT/IL2010/000895 WO2012056441A1 (en) 2010-10-28 2010-10-28 Compositions and methods for specific cleavage of exogenous rna in a cell
PCT/IL2011/000827 WO2012056449A2 (en) 2010-10-28 2011-10-27 Compositions and methods for specific cleavage of exogenous rna in a cell

Publications (2)

Publication Number Publication Date
JP2013544510A JP2013544510A (ja) 2013-12-19
JP2013544510A5 true JP2013544510A5 (enExample) 2014-12-11

Family

ID=45993240

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013535585A Pending JP2013544510A (ja) 2010-10-28 2011-10-27 細胞において外来性rnaを特異的に切断するための組成物および方法

Country Status (8)

Country Link
US (1) US20130225660A1 (enExample)
EP (1) EP2632931A4 (enExample)
JP (1) JP2013544510A (enExample)
CN (1) CN103282372A (enExample)
AU (1) AU2011322106A1 (enExample)
CA (1) CA2815632A1 (enExample)
IL (1) IL226038A0 (enExample)
WO (2) WO2012056441A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010500011A (ja) 2006-08-08 2010-01-07 ガンサー ハートマン 5’リン酸オリゴヌクレオチドの構造および使用
US9738680B2 (en) 2008-05-21 2017-08-22 Rheinische Friedrich-Wilhelms-Universität Bonn 5′ triphosphate oligonucleotide with blunt end and uses thereof
EP2508530A1 (en) 2011-03-28 2012-10-10 Rheinische Friedrich-Wilhelms-Universität Bonn Purification of triphosphorylated oligonucleotides using capture tags
EP2712870A1 (en) 2012-09-27 2014-04-02 Rheinische Friedrich-Wilhelms-Universität Bonn Novel RIG-I ligands and methods for producing them
WO2017171654A1 (en) * 2016-04-01 2017-10-05 National University Of Singapore Trans-splicing rna (tsrna)
DE102017103383A1 (de) * 2017-02-20 2018-08-23 aReNA-Bio GbR (vertretungsberechtigter Gesellschafter: Dr. Heribert Bohlen, 50733 Köln) System und Verfahren zur Zelltyp-spezifischen Translation von RNA-Molekülen in Eukaryoten
WO2022182697A1 (en) * 2021-02-23 2022-09-01 Board Of Regents, The University Of Texas System A novel rna-based approach to cancer treatment

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869248A (en) * 1994-03-07 1999-02-09 Yale University Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences
EP0883344B2 (en) * 1995-12-15 2010-06-09 VIRxSYS Corporation Therapeutic molecules generated by trans-splicing
EP1147188B1 (en) * 1999-01-26 2007-05-16 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Internal ribosome entry site (ires), vector containing same and the uses thereof
WO2004050680A2 (en) * 2002-05-08 2004-06-17 Intronn, Inc. Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses
US20030219407A1 (en) * 2002-05-15 2003-11-27 The Regents Of The University Of California RNA silencing in animals as an antiviral defense
AU2003247696A1 (en) * 2002-07-01 2004-01-19 E.I. Du Pont De Nemours And Company Method of controlling gene silencing using site-specific recombination
EP2000160A3 (en) * 2002-10-30 2009-03-11 Gambro Lundia AB Method and apparatuses for determining the efficiency of dialysis
EP2305813A3 (en) * 2002-11-14 2012-03-28 Dharmacon, Inc. Fuctional and hyperfunctional sirna
WO2005112620A2 (en) * 2004-05-18 2005-12-01 Massachusetts Institute Of Technology A cre-lox based method for conditional rna interference
EP1799825B1 (en) * 2004-10-05 2011-06-29 The California Institute of Technology Aptamer regulated nucleic acids and uses thereof
JP5053850B2 (ja) * 2004-10-08 2012-10-24 バークシス コーポレーション 抗体遺伝子導入および抗体ポリペプチド産生のためのrnaトランススプライシングの使用
CN101184840A (zh) * 2005-03-31 2008-05-21 卡兰朵医药公司 核糖核苷酸还原酶亚基2的抑制剂及其用途
PL1866414T3 (pl) * 2005-03-31 2012-10-31 Calando Pharmaceuticals Inc Inhibitory podjednostki 2 reduktazy rybonukleotydowej i ich zastosowania
WO2007149246A2 (en) * 2006-06-12 2007-12-27 Massachusetts Institute Of Technology Cre-lox based gene knockdown constructs and methods of use thereof
US8158595B2 (en) * 2006-11-09 2012-04-17 California Institute Of Technology Modular aptamer-regulated ribozymes
WO2008106658A2 (en) * 2007-03-01 2008-09-04 California Institute Of Technology TRIGGERED RNAi
US8367815B2 (en) * 2007-08-28 2013-02-05 California Institute Of Technology Modular polynucleotides for ligand-controlled regulatory systems
US9029524B2 (en) * 2007-12-10 2015-05-12 California Institute Of Technology Signal activated RNA interference

Similar Documents

Publication Publication Date Title
Liu et al. Circular RNAs: characterization, cellular roles, and applications
JP2013544511A5 (enExample)
WO2007091269A3 (en) NOVEL TANDEM siRNAS
JP2014527401A5 (enExample)
EP2495248A4 (en) BRIDGED ARTIFICIAL NUCLEOSIDE AND NUCLEOTIDE
JP2016523564A5 (enExample)
Goto et al. A simple and rapid method to detect plant siRNAs using nonradioactive probes
EP3012324A3 (en) Modulation of hsp47 expression
EA200870402A1 (ru) Фармацевтическая композиция
CA2785727A1 (en) Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3)
JP6137484B2 (ja) 遺伝子発現抑制用二本鎖核酸分子
JP2025530174A (ja) 自己環状化rna構造体
Frost et al. Dynamics of DNA methylation and its impact on plant embryogenesis
WO2008039937A3 (en) Blocking of gene expression in eukaryotic cells
ES2651911T3 (es) Métodos mejorados de silenciamiento génico
JP6286050B2 (ja) トリインフルエンザウイルスのmiRNAとその同定、検出および使用
WO2012056441A1 (en) Compositions and methods for specific cleavage of exogenous rna in a cell
JP2006523103A5 (enExample)
Noma et al. A screening method for DNA aptamers that bind to␣ a␣ specific, unidentified protein in tissue samples
WO2016145608A1 (zh) 一种小激活rna及其制备方法和应用
WO2011065677A3 (ko) 암 치료용 약학 조성물
Dunn-Davies et al. Systematic mapping of small nucleolar RNA targets in human cells
CN112226435B (zh) 一组降低尿酸酶基因表达的核苷酸序列及应用
CN104195153B (zh) 一种双顺反子共表达基因转移体及制备方法
WO2006076251A3 (en) Efficient gene suppression using a transfer rna promoter in herpes virus vectors to deliver small interference rnas